VVOS — Vivos Therapeutics, Inc.

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1716166 ·
Last close
$0.08
Market Cap
$1.60M
52W High
$2.69
52W Low
$0.07
ADV30
5,825,694
Next earnings
2026-11-16

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 5,153,000 2,953,000 -4,825,000 -5,481,000 24,144,000 1,774,000 28,130,000
Mar 2026 5,141,000 3,059,000 -6,615,000 -7,682,000 25,043,000 2,110,000 26,310,000
Dec 2025 3,824,000 2,988,000 -6,382,000 -6,954,000 25,152,000 2,029,000 26,702,000
Sep 2025 6,783,000 3,937,000 -4,734,000 -5,400,000 25,644,000 3,087,000 23,112,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-17,131,000
Investing CF
$-1,932,000
Financing CF
$16,435,000
CapEx
$-2,736,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.87
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-138,520,000
Inventory
—
Receivables
$1,438,000
ST Investments
—
EBIT TTM
$-22,556,000
Pretax Income TTM
$-25,628,000
Interest Exp TTM
—
Analysts
2

Yahoo Snapshot (yfinance, live)

Total Revenue
$20,902,000
EBITDA
$-20,763,000
Free Cash Flow
$-8,534,250
Enterprise Value
$15,366,716
Total Cash
$1,774,000
Total Debt
$12,505,000
Shares Out
20,118,023
Trailing EPS
$-1.88
Book Value
$-0.34
ROE
-8585.3%
ROA
-56.2%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 17,443,000 -19,894,000 -21,230,000 25,152,000 26,702,000 -1,490,000 -15,263,000
Dec 2024 15,031,000 -11,171,000 -11,136,000 15,284,000 7,330,000 7,954,000 -12,691,000
Dec 2023 13,801,000 -17,296,000 -13,583,000 10,730,000 10,319,000 411,000 -11,946,000
Dec 2022 16,024,000 -25,031,000 -23,845,000 13,720,000 8,919,000 4,801,000 -19,587,000

TTM Snapshot

Revenues TTM
$20,901,000
NetIncome TTM
$-25,456,000
OpCashFlow TTM
—
Assets (Latest)
$24,144,000
Forward EPS
$-0.82

Peers — same industry

TickerNameMarket CapLastDaily %
CUPR Cuprina Holdings (Cayman) LTD $1.56M $1.69 —
VYCO VYCOR MEDICAL INC $1.47M $0.04 —
ESMC ESCALON MEDICAL CORP $1.40M $0.19 —
NXL Nexalin Technology, Inc. $1.85M $1.50 —
CODX Co-Diagnostics, Inc. $2.06M $0.20 —

News headlines (Yahoo Finance, 1h cache)

Vivos Therapeutics Inc (VVOS) (Q3 2026) Earnings Call Highlights: Cost Cuts, Payer ...
2026-11-18 17:01 · Yahoo
Vivos Therapeutics, Inc. (VVOS) Reports Q3 Loss, Beats Revenue Estimates
2026-11-16 23:55 · Yahoo
Vivos Therapeutics Reports Third Quarter 2026 Financial Results and Provides Operational Update
2026-11-16 23:31 · Yahoo
CORRECTION: SOD Sciences Welcomes Vivos Therapeutics as Strategic Investor and Partner in the ReBalU Primed Cell Test
2026-10-29 14:52 · Yahoo
Vivos Therapeutics Reports Nasdaq Confirmation of Compliance with Continued Listing Shareholders’ Equity Standard
2026-10-21 11:00 · Yahoo
Vivos Therapeutics Closes Acquisition of Stake in SOD Sciences and 50% Interest in Pseudohypoxia Test, Opening a Potential Path to Access More Than 325,000 New Patients Through the AHA Channel
2026-10-19 21:01 · Yahoo
Vivos Therapeutics Agrees to Acquire Minority Stake in SOD Sciences and 50% Interest in Proprietary Pseudohypoxia Test
2026-10-15 12:45 · Yahoo
Vivos Therapeutics Targets $3.6 Million in Annual Cost Reductions as Revenue Growth Initiatives Accelerate
2026-09-29 14:42 · Yahoo
Vivos Therapeutics Reports Progress in Material Cost Reductions and Revenue Growth Initiatives
2026-09-29 12:45 · Yahoo
Vivos Therapeutics Announces Material Debt Reduction
2026-09-08 12:45 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.